Anaphylaxis following quadrivalent human papillomavirus vaccination (Q36856763)

16 August 2017

Anaphylaxis following quadrivalent human papillomavirus vaccination (English)

1 reference

16 August 2017

1 reference

1 reference

1

Julia M L Brotherton

1 reference

16 August 2017

Mike S Gold

2

1 reference

16 August 2017

Andrew S Kemp

3

1 reference

16 August 2017

Peter B McIntyre

4

1 reference

16 August 2017

Margaret A Burgess

5

1 reference

16 August 2017

Sue Campbell-Lloyd

6

1 reference

16 August 2017

New South Wales Health HPV Adverse Events Panel

7

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

Canadian Medical Association Journal

16 August 2017

1 reference

16 August 2017

179

1 reference

16 August 2017

6

1 reference

16 August 2017

525-533

1 reference

Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Developing an HPV vaccine to prevent cervical cancer and genital warts

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Chapter 12: Prophylactic HPV vaccines: underlying mechanisms.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Vaccination-related adverse events

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Hypersensitivity reactions to the polysorbate contained in recombinant erythropoietin and darbepoietin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Kinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvant

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Risk of Anaphylaxis After Vaccination of Children and Adolescents

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Pharmacological effects of formulation vehicles : implications for cancer chemotherapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Age, sex, geographical and socio-economic variations in admissions for anaphylaxis: analysis of four years of English hospital data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Syncope after immunization

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Adverse reaction to the recombinant hepatitis B vaccine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Minimum estimated incidence in Japan of anaphylaxis to live virus vaccines including gelatin

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Anaphylaxis from yellow fever vaccine

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527382

Managing anaphylaxis: effective emergency and long-term care are necessary

4 September 2018

1 reference

12 December 2020

Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions

1 reference

12 December 2020

Removal of gelatin from live vaccines and DTaP-an ultimate solution for vaccine-related gelatin allergy

1 reference

12 December 2020

Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up

1 reference

12 December 2020

Allergic mechanisms and urticaria/angioedema after hepatitis B immunization

1 reference

12 December 2020

Sex in Australia: selected characteristics of regular sexual relationships

1 reference

12 December 2020

Yeast-derived hepatitis B vaccine and yeast sensitivity

1 reference

12 December 2020

Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005

1 reference

12 December 2020

Systemic adverse effects of hepatitis B vaccines are rare

1 reference

12 December 2020

Assessment of a universal, school-based hepatitis B vaccination program

1 reference

12 December 2020

Pitfalls in drug allergy skin testing: false-positive reactions due to (hidden) additives

1 reference

12 December 2020

Clustered sensitivity to fungi: anaphylactic reactions caused by ingestive allergy to yeasts

1 reference

12 December 2020

Allergic reactions to measles-mumps-rubella vaccination

1 reference

12 December 2020

Identifiers

DOI

10.1503/CMAJ.080916

1 reference

16 August 2017

1 reference

16 August 2017

1 reference